Skip to main content
. 2021 Feb 16;21:180. doi: 10.1186/s12879-021-05883-5

Table 4.

Percentage of the susceptibility of Pseudomonas aeruginosa strain to selected antibiotics .Data are presented as number and (%) of the susceptible strains in selected years

Year p-value
Antibiotics/Strains (n) 2011 2012 2013 2014 2015 2016 2017 2018 2019 (01–06)
20 18 7 13 12 5 14 10 9
Piperacillin/ tazobactam 8 (40) 9 (50) 3 (42.9) 7 (53.8) 6 (50) 3 (60) 13 (92.9) 5 (50) 2 (22.2)

p = 0.311

*p = 0.001

Ceftazidime 10 (50) 7 (38.9) 3 (42.9) 8 (61.5) 7 (58.3) 3 (60) 13 (92.9) 6 (60) 3 (33.3)

p = 0.335

*p = 0.0049

Cefepime 13 (65) 9 (50) 3 (42.9) 5 (38.5) 7 (58.3) 3 (60) 14 (100) 6 (60) 3 (33.3)

p = 0.225

*p = 0.0008

Imipenem 11 (55) 7 (38.9) 2 (28.6) 7 (53.8) 7 (58.3) 1 (20) 11 (78.6) 7 (70) 2 (22.2)

p = 0.129

*p = 0.0335

Meropenem 11 (55) 9 (50) 2 (28.6) 7 (53.5) 8 (66.7) 1 (20) 11 (78.6) 6 (60) 2 (22.2)

p = 0.1296

*p = 0.0335

Amikacin 11 (55) 13(2.7) 6 (85.7) 8 (61.5) 10 (83.3) 4 (80) 14 (100) 7 (70) 3 (33.3)

p = 0.427

*p = 0.008

Gentamicin 11 (55) 9 (50) 5 (71.4) 4 (30.8) 8 (66.7) 2 (40) 14 (100) 7 (70) 3 (33.3)

p = 0.427

*p = 0.0008

Ciprofloxacin 9 (45) 6 (33.3) 4 (57.1) 4 (30.8) 7 (58.3) 2 (40) 14 (100) 6 (60) 3 (33.3)

p = 0.4118

*p = 0.0008

Colistin 8 (100) 10 (100) 3 (100) 4 (100) 5 (100) 2 (100) 3 (100) 9 (100)

Notes: p was calculated for the correlation of data 2011 vs. 2019; * p value for 2017 vs. 2019 Abbreviation: n number of P.aeruginosa strains